Trimegah Bangun Persada Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Trimegah Bangun Persada Tbk. trades at Rp885 (market cap 54.26T, 56.47M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 4.6× Tempo Scan Pacific Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (56.47M versus 429.7K). Which is the better fit depends on your goals.
| NCKL | TSPC | |
|---|---|---|
Market Cap | 54.26T | 11.68T |
Volume | 56.47M | 429.7K |
Lot | 564.68K | 4.3K |
Turnover | 50.19B | 1.11B |
Average Price | 888.82 | 2,591.65 |
Value | 50.19B | 1.11B |
Indicative Equilibrium Price | 885 | 2,580 |
Indicative Equilibrium Volume | 11.61K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Read more on NCKL →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →